
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology
Adam Oken, Ipsita Krishnamurthy, Jonathan C. Savage, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Adam Oken, Ipsita Krishnamurthy, Jonathan C. Savage, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Showing 25 citing articles:
Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Purinergic Receptor Activation Protects Glomerular Microvasculature from Increased Mechanical Stress in Angiotensin II-Induced Hypertension: A Modeling Study
Owen Richfield, Ricardo Cortez, Supaporn Kulthinee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1928-1928
Open Access | Times Cited: 1
Owen Richfield, Ricardo Cortez, Supaporn Kulthinee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1928-1928
Open Access | Times Cited: 1
High-affinity agonism at the P2X7 receptor is mediated by three residues outside the orthosteric pocket
Adam Oken, Nicolas E. Lisi, Ipsita Krishnamurthy, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Adam Oken, Nicolas E. Lisi, Ipsita Krishnamurthy, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Role of microglia in diabetic neuropathic pain
Qian Wang, Yilin Xie, Shichao Ma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Qian Wang, Yilin Xie, Shichao Ma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders
Xiaoming Liu, Yiwen Li, Liting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Xiaoming Liu, Yiwen Li, Liting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
P2X7 Receptor in Dendritic Cells and Macrophages: Implications in Antigen Presentation and T Lymphocyte Activation
Claudio Acuña‐Castillo, Alejandro Escobar, Moira García-Gómez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2495-2495
Open Access | Times Cited: 4
Claudio Acuña‐Castillo, Alejandro Escobar, Moira García-Gómez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2495-2495
Open Access | Times Cited: 4
Human P2X4 receptor gating is modulated by a stable cytoplasmic cap and a unique allosteric pocket
Haoyuan Shi, Ismayn A. Ditter, Adam Oken, et al.
Science Advances (2025) Vol. 11, Iss. 3
Open Access
Haoyuan Shi, Ismayn A. Ditter, Adam Oken, et al.
Science Advances (2025) Vol. 11, Iss. 3
Open Access
Characterization of the Active Enantiomer and Mapping of the Stereospecific Intermolecular Pattern of a Reference P2X7 Allosteric Antagonist
Andrew McGown, Nicolas Renault, Amélie Barczyk, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 446-459
Closed Access
Andrew McGown, Nicolas Renault, Amélie Barczyk, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 446-459
Closed Access
UB-MBX-46 is a potent and selective antagonist of the human P2X7 receptor developed by structure-based drug design
Adam Oken, Andreea L. Turcu, Eva Tzortzini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Adam Oken, Andreea L. Turcu, Eva Tzortzini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Sampling the conformational states of P2X receptors with AlphaFold3
Asghar Reza Soltani
Journal of Proteins and Proteomics (2025)
Closed Access
Asghar Reza Soltani
Journal of Proteins and Proteomics (2025)
Closed Access
New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting
Jiazhen Chen, Zezhi He, Xiangnong Dai, et al.
Anais Brasileiros de Dermatologia (2025)
Open Access
Jiazhen Chen, Zezhi He, Xiangnong Dai, et al.
Anais Brasileiros de Dermatologia (2025)
Open Access
The role of ion channels in the regulation of dendritic cell function
Shibin Zhou, Lanlan Zhong, Yi-Lan Wu, et al.
Cell Calcium (2025) Vol. 128, pp. 103031-103031
Closed Access
Shibin Zhou, Lanlan Zhong, Yi-Lan Wu, et al.
Cell Calcium (2025) Vol. 128, pp. 103031-103031
Closed Access
P2X 7 receptors exhibit at least three modes of allosteric antagonism
Adam Oken, Ismayn A. Ditter, Nicolas E. Lisi, et al.
Science Advances (2024) Vol. 10, Iss. 40
Open Access | Times Cited: 3
Adam Oken, Ismayn A. Ditter, Nicolas E. Lisi, et al.
Science Advances (2024) Vol. 10, Iss. 40
Open Access | Times Cited: 3
Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding
Adam Oken, Nicolas E. Lisi, Ismayn A. Ditter, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Adam Oken, Nicolas E. Lisi, Ismayn A. Ditter, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Neurosteroids as positive and negative allosteric modulators of ligand-gated ion channels: P2X receptor perspective
Sonja Sivcev, Eva Kudová, Hana Zemková
Neuropharmacology (2023) Vol. 234, pp. 109542-109542
Closed Access | Times Cited: 6
Sonja Sivcev, Eva Kudová, Hana Zemková
Neuropharmacology (2023) Vol. 234, pp. 109542-109542
Closed Access | Times Cited: 6
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
P2X receptors in GtoPdb v.2023.1
Francesco Di Virgilio, Simonetta Falzoni, Anna Fortuny‐Gomez, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Francesco Di Virgilio, Simonetta Falzoni, Anna Fortuny‐Gomez, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism
Rua'a Al‐Aqtash, Daniel M. Collier
Channels (2024) Vol. 18, Iss. 1
Open Access
Rua'a Al‐Aqtash, Daniel M. Collier
Channels (2024) Vol. 18, Iss. 1
Open Access
Structural Basis of Ion Permeation, Calcium Selectivity, and Pore Blocking at the P2X1 Receptor
Heng Zhang, Pengpeng Wu, Youwei Xu, et al.
(2024)
Closed Access
Heng Zhang, Pengpeng Wu, Youwei Xu, et al.
(2024)
Closed Access
Human P2X4 receptor gating is modulated by a stable cytoplasmic cap and a unique allosteric pocket
Haoyuan Shi, Ismayn A. Ditter, Adam Oken, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Haoyuan Shi, Ismayn A. Ditter, Adam Oken, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes
Guillermo A. Cabral-García, José R. Cruz-Muñoz, Eduardo E. Valdez-Moráles, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1291-1291
Open Access
Guillermo A. Cabral-García, José R. Cruz-Muñoz, Eduardo E. Valdez-Moráles, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1291-1291
Open Access
A comprehensive review of natural product-derived compounds acting on P2X7R: The promising therapeutic drugs in disorders
Zhenling Liu, Wenjin Liu, Mengyao Han, et al.
Phytomedicine (2023) Vol. 128, pp. 155334-155334
Closed Access | Times Cited: 1
Zhenling Liu, Wenjin Liu, Mengyao Han, et al.
Phytomedicine (2023) Vol. 128, pp. 155334-155334
Closed Access | Times Cited: 1
Identification of residues in the first transmembrane domain of the P2X7 that regulates receptor trafficking, sensitization, and dye uptake function
Marian Rupert, Anirban Bhattacharya, Sonja Sivcev, et al.
Journal of Neurochemistry (2023) Vol. 165, Iss. 6, pp. 874-891
Open Access
Marian Rupert, Anirban Bhattacharya, Sonja Sivcev, et al.
Journal of Neurochemistry (2023) Vol. 165, Iss. 6, pp. 874-891
Open Access
Role of purinergic signalling in obesity-associated end-organ damage: focus on the effects of natural plant extracts
Hangxiu Che, Yaqun Wang, Jinhui Lao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access
Hangxiu Che, Yaqun Wang, Jinhui Lao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access
Diclofenac and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are Competitive Antagonists of the human P2X3 Receptor
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access